Specific antibodies to Trypanosoma cruzi among blood donors in Los Angeles, California

Transfusion

Volumn 37, Issue 7, 1997, Pages 727-731

  Shulman, I A ^a,b   Appleman, M D ^c   Saxena, S ^c   Hiti, A L ^a   Kirchhoff, L V ^d,e  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b LAC USC MEDICAL CENTER   (United States)

^c Univ of S California Sch of Med   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CLINICAL ARTICLE; DISEASE TRANSMISSION; ENDEMIC DISEASE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; INFECTION RISK; MALE; PREVALENCE; RISK ASSESSMENT; TRYPANOSOMIASIS; UNITED STATES;

EID: 0030836810     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1997.37797369449.x     Document Type: Article

References (19)

1. Kirchhoff LV. American trypanosomiasis (Chagas' disease) -a tropical disease now in the United States. N Engl J Med 1993;329:639-44.
2. Ochs DE, Hnilica V, Moser DR, et al. Postmortem diagnosis of autochthonous acute chagasic myocarditis by polymerase chain reaction amplification of a species-specific DNA sequence of Trypanosoma cruzi. Am J Trop Med Hyg 1996;54:526-9.
3. Schmunis GA. Trypanosoma cruzi, the etiologic agent of Chagas' disease: status in the blood supply in endemic and nonendemic countries. Transfusion 1991;31:547-57.
4. Kirchhoff LV. Is Trypanosoma cruzi a new threat to our blood supply? Ann Intern Med 1989;111:773-5.
5. Kirchhoff LV, Gam AA, Gilliam FC. American trypanosomiasis (Chagas' disease) in Central American immigrants. Am J Med 1987;82:915-20.
6. Geiseler PJ, Ito JI, Tegtmeier BR, et al. Fulminant Chagas disease (CD) in bone marrow transplantation (BMT) (abstract). In: Abstracts of the 1987 Interscience Conference on Antimicrobial Agents and Chemotherapy, New York, NY, October 1987:169.
7. Grant IH, Gold JWM, Wittner M, et al. Transfusion-associated acute Chagas disease acquired in the United States. Ann Intern Med 1989;111:849-51.
8. Cimo PL, Luper WE, Scouros MA. Transfusion-associated Chagas' disease in Texas: report of a case. Tex Med 1993;89:48-50.
9. Nickerson P, Orr P, Schroeder M, et al. Transfusion-associated Trypanosoma cruzi infection in a non-endemic area. Ann Intern Med 1989;111:851-3.
10. Cerisola JA, Rabinovich A, Alvarez M, et al. [Chagas' disease and blood transfusion] (Engl abstract). Bol Oficina Sanit Panam 1972;63:203-21.
11. Sullivan TS. Viability of Trypanosoma cruzi in citrated blood stored at room temperature. J Parasitol 1944;30:200.
12. Filardi LS. Cryopreservation of Trypanosoma cruzi blood-stream forms. J Protozool 1975;22:398-401.
13. Rocha A, de Meneses AC, da Silva AM, et al. Pathology of patients with Chagas' disease and acquired immunodeficiency syndrome. Am J Trop Med Hyg 1994;50:261-8.
14. Kerndt PR, Waskin HA, Kirchhoff LV, et al. Prevalence of antibody to Trypanosoma cruzi among blood donors in Los Angeles, California. Transfusion 1991;31:814-8.
15. Appleman MD, Shulman IA, Saxena S, Kirchhoff LV. Use of a questionnaire to identify potential donors at risk for infection with Trypanosoma cruzi. Transfusion 1993;33:61-4.
16. Kirchhoff LV, Gam AA, Gusmao Rd, et al. Increased specificity of serodiagnosis of Chagas' disease by detection of antibody to the 72-and 90-kilodalton glycoproteins of Trypanosoma cruzi. J Infect Dis 1987;155:561-4.
17. Leiby DA, Read EJ, Lenes BA, et al. Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas' disease, in U.S. blood donors. J Infect Dis (in press).
18. Galel S, Kirchhoff LV. Risk factors for Trypanosoma cruzi infection in California blood donors. Transfusion 1996;36:227-31.
19. Laranja FS, Dias E, Nobrega G, Miranda A. Chagas' disease: a clinical, epidemiologic, and pathologic study. Circulation 1956;14:1035-60.